Heat stress can cause significant reproductive dysfunction in mammals and previous studies 23 report that expression and activity of cathepsin B (CTSB), a lysosomal cysteine protease, is 24 negatively correlated with the developmental competence of bovine oocytes and embryos. 25 However, the relationship between heat shock (HS) and CTSB remains largely unknown. Here, 26
Introduction 39
Reproductive processes in mammals are very sensitive to hyperthermia, which can cause 40 significant decreases in fertility in females and sperm quality in males. Hyperthermia occurs 41 when high ambient temperatures (typically >27°C) cause body temperature to rise to between 42 40°C and 42°C [1, 2] . Notably, exposing cows to hyperthermic heat stress reduces their 43 conception rate and affects subsequent embryonic development [3] . In vivo studies indicate that 44 the observed reduction in conception rate can occur quickly and potentially be affected by 45 elevated body temperature on the day of insemination [1, 4, 5] . Furthermore, multiple in vitro 46 studies reported that high temperatures during the period from oocyte maturation to 47 preimplantation embryo development degrade oocyte quality and developmental competence by 48 promoting oxidative stress and DNA damage [6] [7] [8] [9] [10] [11] [12] . Similarly, oocyte competency with regard 49 to fertilization and blastocyst formation was also reduced by high temperature during fertilization 50 in vitro [11] . Together, these data suggest that the mechanism by which heat stress affects 51 fertility and embryo viability is multifactorial and likely involves many aspects of reproductive 52 physiology. Because heat stress effects reproductive health, many attempts have been made to 53 improve the developmental competence of heat-shocked oocytes and embryos via changes in 54 media composition or supplementation. Interestingly, the addition of chemicals or antioxidants, 55 such as insulin-like growth factor-1 [13] , 2-mercaptoethanol [12, 14] , astaxanthin [15] , 56
anthocyanins [16] , melatonin [17, 18] , and coagulansin-A [19] , into the culture medium appears 57 to enhance oocyte and embryo quality, as well as improve developmental competence during 58 heat shock (HS). 59
Cathepsin B (CTSB) is a lysosomal cysteine protease that participates in the degradation of 60 intracellular proteins in lysosomes [20] . CTSB is synthesized as an enzyme precursor in an 61 inactive form prior to post-translational processing into its active form after passing through the 62 endoplasmic reticulum and subsequent incorporation into the acidic environment of the lysosome 63 [21, 22] . The active form of CTSB has disulfide-linked heavy and light-chain subunits and a 64 molecular weight of 30 kDa [23] . CTSB is also involved in many physiological and pathologicalprocesses, including initiation of the apoptosis pathway, remodeling of extracellular matrix, 66 autophagy, cancer differentiation, and inflammation [24, 25] . CTSB expression is detected in 67 many types of cells, including ovaries and cumulus cells [26, 27] . Bettegowda et al. [26] reported 68 that higher expression of CTSB mRNA was observed in cumulus cells from prepubertal cows, 69 which are a model with poor oocyte competence, relative to levels observed in adult cows. We 70 also reported that higher CTSB activity was observed in low-quality bovine cumulus-oocyte 71 complexes (COCs) and embryos as compared with that observed in those of better quality. 72
Additionally, CTSB also plays a role in apoptosis, which is associated with low developmental 73 competence in both COCs and embryos [28, 29] . Importantly, addition of a CTSB inhibitor 74 (E-64) to the culture medium improved developmental competence in low-quality oocytes and 75 embryos. Moreover, CTSB inhibition also improved blastocyst quality via regulation of the 76 apoptosis pathway [28, 29] . Although bovine oocytes exposed to HS during in vitro maturation 77 also exhibited increased CTSB activity, low developmental competence, and increased apoptosis, 78 these changes could be counteracted by CTSB inhibition [30] . Despite these findings, our 79 understanding of how CTSB inhibitors function under HS conditions during fertilization and 80 early embryo development is limited. 81
In this study, we clarified the relationship between CTSB activity and low developmental 82 competence caused by HS during fertilization and early embryonic development using in vitro 83 culture techniques. Furthermore, we also investigated the effect of CTSB inhibition on the 84 developmental competence of HS-treated embryos. To our knowledge, this is the first study 85 investigating the role of CTSB and the benefits of its inhibition during HS-induced changes at 86
Detection of intracellular CTSB activity 120
Detection of embryonic CTSB activity was performed using a Magic red CTSB detection kit 121 
Experimental design 147
We conducted three experiments described as follows and illustrated in Figure 1 . 148 149
Experiment 1: effect of CTSB inhibitor (E-64) on the development of embryos exposed to 150

HS during IVF or early IVC 151
To assess the effects of E-64 supplementation on HS-mediated changes in embryonic 152
development, E-64 at different concentrations (0, 0.1, 0.5, and 1.0 µM) was added to the medium 153 during HS treatment. To examine the effect of HS treatment at different times on developmental 154 competence, HS treatment under two different conditions was conducted as follows: 1) at 40.0ºC 155 for 6 h during IVF and 2) at 40.0ºC for 20 h after the beginning of IVC, during which almost all 156 viable embryos complete the first cleavage [32] . After HS treatment, embryos were cultured at 157 38.5ºC in E-64-free medium until day 8 (day 0 represents the day of insemination). 158
Developmental competence was assessed by cleavage and blastocyst rates on days 2 and 8, 159
respectively. 160 161
Experiment 2: effect of HS and CTSB inhibitor on CTSB activity in HS-exposed embryos 162
We then examined weather HS increass CTSB activity, and whether this change could be 163
inhibited by E-64. Matured oocytes and/or zygotes were cultured with 0.5 µM E-64, followed by 164 exposure to HS at 40.0ºC for 6 h during IVF or for 20 h after the beginning of IVC. The number 165 of fluorescent dots highlighting the active form of CTSB was analyzed immediately following 166 HS treatment. 167 168
Experiment 3: effect of CTSB inhibitor on the quality of blastocysts derived from 169
HS-exposed embryos 170
To examine the effects of HS and E64 inhibition on blastocyst quality, matured oocytes or 171 zygotes were cultured with 0.5 µM E-64 and exposed to HS at 40.0ºC for 6 h during IVF or for 172
Developmental rate (cleavage rate on day 2 and blastocyst rate on day 8), total cell number, and 174 apoptotic status of day 8 blastocysts were analyzed. 175 176
Statistical analysis 177
Each experiment was repeated at least five times. Data are expressed as the mean ± standard 178 error. All data were analyzed using analysis of variance (ANOVA), followed by the 179 Tukey-Kramer multiple comparison test. All percentage data were arcsine transformed prior to 180 statistical analysis. A P < 0.05 was considered statistically significant. 181 182 183
Results 184
Inhibition of CTSB activity improves the developmental competence of bovine embryos 185 exposed to HS during IVF or early IVC 186
HS during IVF decreased the developmental rate of embryos as compared with that observed in 187 the control group (P < 0.05). However, embryos cultured with E-64 (0.5 µM) under the same HS 188 conditions increased the developmental rate of embryos to a rate similar to that observed in the 189 control group (Table 1) . As shown in Table 2 , HS during early IVC decreased the developmental 190 rate to blastocyst stage as compared with control group (P < 0.05); however, this rate was 191 increased by addition of 0.5 μM E-64 to the culture medium under HS conditions (P < 0.05), 192 although the rate was lower than that in the control groups (P < 0.05). Based on these results, we 193 selected the E-64 concentration that had the greatest effect on the developmental competence of 194 HS-treated embryos. Therefore, all subsequent experiments were performed using 0.5 μM E-64. 195 196
HS increases intracellular CTSB activity in bovine embryos 197
To investigate the relationship between elevated temperature during culture and CTSB activity in 198 embryos, HS treatment was applied during IVF (6 h) or early IVC (20 h). CTSB activity was 199 detected immediately following HS treatment. As shown in Figure 1A , the active form of CTSB 200 was clearly detected in the cytoplasm, with the number of fluorescent dots counted and used as 201 an indicator of CTSB activity. Notably, the average number of fluorescent dots was higher in the 202 HS-treated group relative to that observed in the control and HS+E-64 groups under both 203 HS-treatment conditions (6 h during IVF: P < 0.01, Fig. 1B ; 20 h in early IVC: P < 0.01, Fig.  204   1C) . Additionally, the average number of fluorescent dots in embryos exposed to HS during 205 early IVC was higher as compared with that in embryos exposed to HS during IVF (74.1 ± 12.2 206 vs. 46.6 ± 6.1, respectively; P < 0.05). By contrast, addition of E-64 to the culture medium 207 reduced the number of fluorescent dots induced by HS (P < 0.01; Fig. 1B and C) . 208 209
Inhibition of CTSB activity improves the quality of HS-treated embryos by decreasing 210 apoptosis in the blastocyst stage 211
Incubation of embryos at elevated temperatures during IVF and early IVC reduced the 212 developmental rate in the blastocyst stage (P < 0.05), whereas the addition of E-64 increased the 213 developmental rate as compared with embryos cultured without E-64 under HS conditions (P < 214 0.05; Figs. 2A and 3A) . HS during IVF also reduced the cleavage rate, which was again 215 increased by treatment with E-64 ( Fig. 2A) . The total cell number and apoptotic status of the 216 blastocysts were also assessed to investigate embryo quality. HS during IVF had no significant 217 effect on the total cell number or the percentage of apoptotic cells in the blastocyst stage (Fig. 2B  218 and C). By contrast, although no difference was found in the total cell number among groups, the 219 percentage of apoptotic cells in the blastocyst stage increased when embryos were exposed to HS 220 during early IVC (P < 0.01; Fig. 3C ). Furthermore, E-64 treatment decreased the percentage of 221 apoptotic cells in these HS-affected blastocysts (P < 0.01) to a level similar to that in the control 222 group (Fig. 3C) . 223 One particularly interesting result in the present study indicated that HS during IVF reduced 257 the cleavage rate, but that the same effect was not observed during early IVC. We previously 258
showed that HS during IVF decreases the cleavage rate by compromising the anti-polyspermy 259 systems of oocytes [11] . Oxidative stress also plays a role in these effects, as it can damage 260 sperm-cell structures and decreases subsequent embryonic development when the damaged 261 sperm are applied for IVF [37] . These findings indicate that HS during IVF could impair 262 processes in both the oocyte and sperm, resulting in decreased cleavage. On the other hand, the 263 inhibition of CTSB activity increased the cleavage rate of embryos fertilized under HS. 264
Collectively, increased CTSB activity in response to any form of cellular stress might be the key 265 to understanding the observed changes in fertilization rates and embryo competency. Leakage of lysosomal enzymes also induces apoptosis. Apoptosis is a normal physiological 280 process often used as a quality marker in preimplantation embryo development both in vivo andin vitro [45] [46] [47] [48] . Previous studies report that HS induces apoptosis in preimplantation embryos 282 [49, 50] . Furthermore, in the present study, we also showed that HS during early IVC increased 283 the number of apoptotic cells in the blastocyst stage. The mechanism underlying these effects 284 appeared to be related to mitochondrial function, whereby HS-induced increases in 285 reactive-oxygen-species production triggers mitochondrial-permeability transition pore opening, 286 followed by release of cytochrome c to the cytosol. These changes cause apoptosis in somatic 287 cells [51, 52] , as well as bovine embryos [6, 12, 14, 53] . More importantly, previous studies 288 report that CTSB can promote this process via induction of mitochondrial-membrane 289 degradation [54, 55] . These studies are supported by our present observation that CTSB 290 inhibition significantly decreased apoptosis in HS-treated embryos. Interestingly, HS during IVF 291 had no significant effect on apoptosis at the blastocyst stage, even though increased CTSB 292 activity was observed after HS treatment. This discrepancy might be related to the difference in 293 the duration of HS treatment, which was shorter during IVF (6 h) as compared with early IVC 294 (20 h). Moreover, CTSB activity in embryos exposed to HS during IVF was also lower than that 295 in embryos exposed to HS during early IVC, indicating that this treatment time was not long 296 enough to induce the level of CTSB activity needed for activation of apoptosis-signaling 297 pathways. Although we observed variable responses depending on the in vitro stage (IVF vs. 298 early IVC) and the duration of HS treatment (6 h vs. 20 h), the mechanism underlying the effects 299 of HS likely involves lysosome leakage leading to CTSB activation, which causes a subsequent 300 increase in apoptosis and, ultimately, dysfunctional embryo development. 301
In conclusion, our results showed that CTSB activity was elevated by HS during IVF and 302 early IVC. Moreover, inhibition of CTSB enhanced the developmental competence and quality 303 of HS-treated bovine embryos, suggesting that excess CTSB activity was indeed involved in the 304 early IVC (C). HS and HS+E-64 groups were supplemented with and without 0.5 µM E-64 485 during HS treatment, respectively. In the control group, IVF and IVC were performed without 486
HS and E-64 supplementation. Data represent the mean ± standard error. Bars labeled with 487 different letters represent significant differences (P < 0.01). 488 CTSB, cathepsin B; E-64, cathepsin inhibitor; HS, heat shock. 489 Cleavage rate BL rate
